Grey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T Magnetic Resonance Imaging Study

Status unknownNot a drug-phase studyMS (type not specified)NCT03659981

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • MRI 7T

What it measured

Main measures

  • number of cortical lesions

    2 hours

    MRI lesions

Who could take part

MS (type not specified) · 18 to 50

Show the full criteria

Inclusion criteria

* First presumed inflammatory demyelinating event in the central nervous system involving either the optic nerve, the spinal cord, a brain hemisphere, or the brainstem without spatial and time dissemination criteria * Oligoclonal bands on CSF analysis * Age between 18 and 45 * No previous history of neurological symptoms suggestive of demyelination * No steroids in the month before MRI * First MRI within six months after the first clinical episode

Exclusion criteria

* Possible alternative diagnoses * Previous history of neurological or psychiatric disease * Previous administration of immunosuppressive drugs * Pregnancy * Patient unable to give his consent for the study or patient under tutorship

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The present study is an opportunity to assess grey matter damage at the earliest phase of Multiple Sclerosis (MS) allowing to a better understanding of its origins and its impact and disease severity. This study is a preliminary longitudinal study to precisely depict the kinetic of grey matter damage and the links with disease aggravation. Thirty MS patients without time and spatial dissemination criteria (only one symptomatic MRI lesion detected) but with oligoclonal bands detected on cerebro spinal fluid analysis will be included for a monocentric transversal MRI study at 7T to assess grey matter injury. Clinical and neuropsychological assessments will be performed in the population the same day of a multi-parametric MRI. A longitudinal clinical and MRI follow up will be performed during 2 years.

Loading reviews and guidelines…

History

  1. Status changed from Running, not recruiting to Status unknown
  2. Result signal changed from Ongoing to Status unknown
  1. Started

    Dec 2018

  2. Main results due

    May 2022

  3. Finished

    Nov 2026

Assembled by software from public sources.